Feb 17 (Reuters) - Memphasys Ltd MEM.AX
* Provides following details and a summary of dispute resolution process it has commenced
* Prime Biologics Pte Ltd ("Prime") and Memphasys Ltd have agreed by mutual consent in legal proceedings in Nsw Supreme Court
* Now filed an application for arbitration in Singapore to hear and resolve dispute between Memphasys, Prime Biologics and Manukan
* Arbitration will primarily deal with s$4.8 million debt associated with fit-out of rental facility that prime is using in singapore
* Memphasys remains optimistic that a positive outcome from arbitration process will be achieved Source text for Eikon: ID:nASXv3YHL Further company coverage: MEM.AX